Dr. Partha Banerjee has worked in the Critical Care field since 1996. He works as the CEO of ARC Dubai, a Renal Health Care Centre in Dubai that is known as Renasense. He managed patient care modules for Aventis, Ell Lilly, Novartis, and Pfizer, as well as the launch of Novartis' immunosuppressive medications. He has supervised business operations in more than 60 countries for major companies such as Imperial Chemical, Johnson Matthey, and CTI as a global multi-faceted expert. He has successfully created and managed many business units in India, the Gulf, continental Europe, and Africa, including multiple Renal Care Centers.

1. Dr. Partha
Banerjee
CEO of ARC
Dubai

2. Dr. Partha Banerjee has worked in the Critical Care
field since 1996. He works as the CEO of ARC Dubai, a
Renal Health Care Centre in Dubai that is known as
Renasense. He managed patient care modules for
Aventis, Ell Lilly, Novartis, and Pfizer, as well as the
launch of Novartis' immunosuppressive medications.

3. In the United States, the United Kingdom,
mainland Europe, Africa, the Gulf, China, and
India, Dr. Banerjee has nearly three decades
of experience in strategy development and
strategic positioning, introducing
formulations, and establishing patient
relationship management.

4. Dr. Banerjee is also the CEO of AI Mazroui Medical centre in
Abu Dhabi, UAE where he has set up AI Razeen Field Hospital
just in 9 days which can last for 10 years. For a few years, he
also worked as the MD and CEO of Nipro Tube Glass Ltd., a
global manufacturer of glass products and various medical
devices that are used for the purpose of dialysis, transfusion,
diagnostics, interventional, cardiopulmonary, and other
pharmaceutical products, before moving to Dubai to pursue a
new career path.